IASO Clinical · CDP Portal
Restricted受限访问
BCMA · Multiple Myeloma多发性骨髓瘤

IASO206
In Vivo BCMA CAR-T
IASO206
体内 BCMA CAR-T

Multiple Myeloma · RRMM多发性骨髓瘤 · RRMM

Program overview of the BCMA in vivo CAR-T development plan — strategy, mechanism, landscape, clinical phases, regulatory & governance. Bilingual.BCMA 体内 CAR-T 开发计划概览——策略、机制、竞争格局、临床分期、注册与治理。中英双语。

Restricted受限访问 Open进入
NEW新方向 AL Light-chain AmyloidosisAL 轻链淀粉样变拓展
Restricted · sign-in受限 · 需登录
CD20 · B-cell LymphomaB 细胞淋巴瘤

IASO208
In Vivo CD20 CAR-T
IASO208
体内 CD20 CAR-T

Relapsed/Refractory B-NHL复发/难治 B 细胞非霍奇金淋巴瘤

Full Clinical Development Plan platform — Phase 1–3 design, endpoints & statistics, regulatory path, protocol portfolio and tri-party review workspace.完整临床开发计划平台——Phase 1–3 设计、终点与统计、注册路径、方案组合与三方审阅工作区。

Sign-in required需身份验证 Enter进入
© 2026 IASO Bio · 驯鹿生物 — Confidential© 2026 驯鹿生物 · IASO Bio — 内部保密